0000899243-18-021374.txt : 20180803 0000899243-18-021374.hdr.sgml : 20180803 20180803160655 ACCESSION NUMBER: 0000899243-18-021374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180801 FILED AS OF DATE: 20180803 DATE AS OF CHANGE: 20180803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Price David CENTRAL INDEX KEY: 0001449336 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 18991865 MAIL ADDRESS: STREET 1: C/O CORNERSTONE THERAPEUTICS INC STREET 2: 1255 CRESCENT GREEN DRIVE SUITE 250 CITY: CARY STATE: NC ZIP: 27518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-01 0 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001449336 Price David C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 0 1 0 0 Chief Financial Officer Employee Stock Option (right to buy) 2.22 2018-08-01 4 A 0 385000 0.00 A 2028-08-01 Common Stock 385000 385000 D The option to purchase will vest and become exercisable in three equal annual installments beginning August 1, 2019. /s/ John Mercer, Attorney-in-Fact 2018-08-03